Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis

Yu, Yue; He, Jie
June 2013
Frontiers of Medicine;Jun2013, Vol. 7 Issue 2, p157
Academic Journal
No abstract available.


Related Articles

  • PET/CT in the Staging of the Non-Small-Cell Lung Cancer. Fangfang Chao; Hong Zhang // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT),...

  • Molecular Markers of Various Stages of Non-Small-Cell Lung Cancer. Zborovskaya, I. B.; Tatosyan, A. G. // Molecular Biology;Mar/Apr2004, Vol. 38 Issue 2, p155 

    Studies performed in the recent decade in the Laboratory of the Regulation of Cell and Virus Oncogenes associated structural and functional defects of several oncogenes and tumor suppressor genes with various stages of non-small-cell lung cancer. High risk of lung cancer was established for...

  • Use of Markers for the Detection and Treatment of Lung Cancer. Vourlekis, Jason S.; Szabo, Eva // Disease Markers;2004, Vol. 20 Issue 2, p71 

    The unacceptably high morbidity and mortality associated with the diagnosis of lung cancer mandates new approaches toward the early detection and treatment of this disease. Enhanced understanding of the molecular biology of the carcinogenic process is identifying many potential markers of risk...

  • Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Kerr, K. M.; Bubendorf, L.; Edelman, M. J.; Marchetti, A.; Mok, T.; Novello, S.; O'Byrne, K.; Stahel, R.; Peters, S.; Felip, E. // Annals of Oncology;Sep2014, Vol. 25 Issue 9, p1681 

    This Second ESMO Consensus Conference on Lung Cancer article focuses on non-small-cell lung cancer pathology and molecular biomarkers.To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The...

  • Prognosis and Diagnosis.  // Current Medical Literature: Lung Cancer;2011, Vol. 4 Issue 3, p88 

    The article discusses several studies on lung cancer prognosis and diagnosis. A retrogressive study investigated the long term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to three centimeter maximum dimension. Another study examined the...

  • Advances in the study of serum tumor markers of lung cancer. Wenjie Qi; Xuechang Li; Jingbo Kang // Journal of Cancer Research & Therapeutics;2014 Special Issue2, Vol. 10, pC95 

    Lung cancer is among the most prevalently occurring carcinomas worldwide, and reducing lung cancer mortality depends on early detection, diagnosis, and treatment. Given the rapid development of molecular biology and modern techniques for diagnosis and treatment, the study of serum tumor markers...

  • NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance. BLACK, ROBERT C.; KHURSHID, HUMERA // Rhode Island Medical Journal;Oct2015, Vol. 98 Issue 10, p25 

    Lung cancer is the most common malignancy in the US and causes the most cancer-related deaths. Non-smallcell lung carcinoma (NSCLC) accounts for the majority of cases. NSCLC historically was considered one entity, reflected by platinum-based therapy as the standard of care; however, with the...

  • Adjuvant Chemotherapy with Cisplatin for Lung Cancer. Zepf, Bill // American Family Physician;9/1/2004, Vol. 70 Issue 5, p978 

    Deals with the use of adjuvant chemotherapy with cisplatin for lung cancer. Standard of care in the treatment of non-small-cell lung cancer.

  • Diagnosis and Prognosis.  // Current Medical Literature: Lung Cancer;2011, Vol. 5 Issue 2, p43 

    The article discusses research on diagnosis and prognosis of lung cancer. It references several studies, including "Longitudinal Perceptions of Prognosis and Goals of Therapy in Patients With Metastatic Non-small-cell Lung Cancer: Results of a Randomized Study of Early Palliative Care," "Ethnic...

  • Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Besse, B. // Annals of Oncology;May2007 Supplement 2, Vol. 18, pii30 

    The article presents clinical recommendations of the European Society for Medical Oncology (ESMO) for the diagnosis, treatment and follow-up of non-small-cell lung cancer. Its pathological diagnosis is in accordance to the World Health Organization classification. Staging and risk assessment may...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics